Ascend Gene & Cell Therapies specializes in advanced therapy manufacturing, focusing on the development and production of adeno-associated virus (AAV) gene therapies. The company emphasizes a commitment to quality and adaptability, ensuring that their manufacturing processes are tailored to meet the specific needs of their partners. Ascend's scalable AAV manufacturing platform is designed to support clients throughout the entire development cycle, from pre-clinical to clinical stages. Their extensive analytical capabilities further enhance the reliability and effectiveness of the therapies produced.

In addition to their manufacturing expertise, Ascend is dedicated to fostering partnerships that accelerate the delivery of life-changing therapies to patients. The company has invested in enabling technologies that allow for flexibility in their processes, ensuring that they can accommodate various project requirements. Recent advancements, such as the installation of a next-generation flexible fill-finish system at their Alachua facility, highlight Ascend's commitment to enhancing their production capabilities and expanding their operational capacity in the United States.

United States

The company supports cell and gene therapy manufacturing and process development projects from design through to clinical and commercial scale.

Ascend Gene & Cell Therapies

Company Details